Treatment Results of Combined Surgery and Brachytherapy, and the Rate of Recurrence in Patients with Recurrent Keloid Scars
|
A.R. Taheri1 , N. Rahmanpanah * 2, M. Aghili3 , D. Nazemi Salman4 , Z. Hosseinzadeh5 |
1- Department of Plastic and Reconstructive Surgeon, Tehran University of Medical Science, Tehran, Iran 2- Department of Plastic and Reconstructive Surgeon, Kordestan University of Medical Science, Sanandaj, Iran 3- Department of Radiotherapy, Tehran University of Medical Science, Tehran, Iran 4- Department of Plastic and Reconstructive Surgeon, Zanjan University of Medical Science, Zanjan, Iran 5- Department of Nursing, Imam Khomeini Hospital Tehran, Iran |
|
Abstract: (4449 Views) |
Background: Several options are described to treat keloid scars, none of them being 100% successful. Radiotherapy is suggested to have the most significant effect on recurrence rate. The aim of the study is to evaluate the effectiveness of High-dose brachytherapy combined with surgery and to evaluate patient satisfaction.
Methods and Material: We retrospectively enrolled 5 patients with 10 keloids, treated by surgical excision and high-dose-rate (HDR) brachytherapy. Total dose was 12 Gy in 3 fractions.
Results: The median size of the lesions before brachytherapy was 153.48 mm2. The improvement of scars of scoring POSAS by observer and patient were 17.1±3.2 (11-32) and 20.8±11.5 (5-51), respectively. Mean of recurrent time was 26.3±0.9 months. With a median follow-up of 60 months, the overall recurrence-free response rate for all keloids was 20%. Except for one patient, in other patients seen no complications.
Conclusion: It seems that keloid excision followed by HDR brachytherapy is effective in the eradication of keloids in treatment. It also resulted in a good cosmetic rate and relief of symptoms. |
|
Keywords: Keloid, High-dose brachytherapy, Excision, Cosmetic, Relief |
|
Full-Text [PDF 216 kb]
(1457 Downloads)
|
Type of Study: Research |
Subject:
Special Received: 2016/11/09 | Accepted: 2016/11/09 | Published: 2016/11/09
|
|
|
|
|
Add your comments about this article |
|
|